1 – 10 of 82
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2025
- 
                        Mark
        Cellular and molecular cartography of muscle-invasive bladder cancer: Who benefits from neoadjuvant chemotherapy?
    (2025) In Lund University, Faculty of Medicine Doctoral Dissertation Series- Thesis › Doctoral thesis (compilation)
 
- 
                        Mark
        Prospective evaluation of surgical treatment of liver metastasizing pancreatic cancer - ScanPan study protocol
    
    - Contribution to journal › Article
 
- 2024
- 
                        Mark
        The Vitamin D Receptor as a Prognostic Marker in Breast Cancer-A Cohort Study
    
    - Contribution to journal › Article
 
- 
                        Mark
        High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
    
    - Contribution to journal › Article
 
- 
                        Mark
        The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma
    
    - Contribution to journal › Article
 
- 
                        Mark
        The prognostic value of programmed death-ligand 1 (PD-L1) expression in resected colorectal cancer without neoadjuvant therapy - differences between antibody clones and cell types
    
    - Contribution to journal › Article
 
- 2023
- 
                        Mark
        CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer.
    
    - Contribution to journal › Article
 
- 2022
- 
                        Mark
        Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer
    
    - Contribution to journal › Article
 
- 
                        Mark
        High infiltration of CD68+/CD163- macrophages is an adverse prognostic factor after neoadjuvant chemotherapy in esophageal and gastric adenocarcinoma
    
    - Contribution to journal › Article
 
- 
                        Mark
        A Prospective Diet-Wide Association Study for Risk of Colorectal Cancer in EPIC
    
    - Contribution to journal › Article
 
